1 Study Coverage
    1.1 Radiopharmaceuticals Product Introduction
    1.2 Market by Type
        1.2.1 Global Radiopharmaceuticals Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Diagnostic Radioisotopes
        1.2.3 Therapeutic Radioisotopes
    1.3 Market by Application
        1.3.1 Global Radiopharmaceuticals Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Oncology
        1.3.3 Cardiology
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Radiopharmaceuticals Sales Estimates and Forecasts 2017-2028
    2.2 Global Radiopharmaceuticals Revenue Estimates and Forecasts 2017-2028
    2.3 Global Radiopharmaceuticals Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Radiopharmaceuticals Sales by Region
        2.4.1 Global Radiopharmaceuticals Sales by Region (2017-2022)
        2.4.2 Global Sales Radiopharmaceuticals by Region (2023-2028)
    2.5 Global Radiopharmaceuticals Revenue by Region
        2.5.1 Global Radiopharmaceuticals Revenue by Region (2017-2022)
        2.5.2 Global Radiopharmaceuticals Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Radiopharmaceuticals Sales by Manufacturers
        3.1.1 Global Top Radiopharmaceuticals Manufacturers by Sales (2017-2022)
        3.1.2 Global Radiopharmaceuticals Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Radiopharmaceuticals in 2021
    3.2 Global Radiopharmaceuticals Revenue by Manufacturers
        3.2.1 Global Radiopharmaceuticals Revenue by Manufacturers (2017-2022)
        3.2.2 Global Radiopharmaceuticals Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Radiopharmaceuticals Revenue in 2021
    3.3 Global Radiopharmaceuticals Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Radiopharmaceuticals Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Radiopharmaceuticals Sales by Type
        4.1.1 Global Radiopharmaceuticals Historical Sales by Type (2017-2022)
        4.1.2 Global Radiopharmaceuticals Forecasted Sales by Type (2023-2028)
        4.1.3 Global Radiopharmaceuticals Sales Market Share by Type (2017-2028)
    4.2 Global Radiopharmaceuticals Revenue by Type
        4.2.1 Global Radiopharmaceuticals Historical Revenue by Type (2017-2022)
        4.2.2 Global Radiopharmaceuticals Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Radiopharmaceuticals Revenue Market Share by Type (2017-2028)
    4.3 Global Radiopharmaceuticals Price by Type
        4.3.1 Global Radiopharmaceuticals Price by Type (2017-2022)
        4.3.2 Global Radiopharmaceuticals Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Radiopharmaceuticals Sales by Application
        5.1.1 Global Radiopharmaceuticals Historical Sales by Application (2017-2022)
        5.1.2 Global Radiopharmaceuticals Forecasted Sales by Application (2023-2028)
        5.1.3 Global Radiopharmaceuticals Sales Market Share by Application (2017-2028)
    5.2 Global Radiopharmaceuticals Revenue by Application
        5.2.1 Global Radiopharmaceuticals Historical Revenue by Application (2017-2022)
        5.2.2 Global Radiopharmaceuticals Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Radiopharmaceuticals Revenue Market Share by Application (2017-2028)
    5.3 Global Radiopharmaceuticals Price by Application
        5.3.1 Global Radiopharmaceuticals Price by Application (2017-2022)
        5.3.2 Global Radiopharmaceuticals Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Radiopharmaceuticals Market Size by Type
        6.1.1 North America Radiopharmaceuticals Sales by Type (2017-2028)
        6.1.2 North America Radiopharmaceuticals Revenue by Type (2017-2028)
    6.2 North America Radiopharmaceuticals Market Size by Application
        6.2.1 North America Radiopharmaceuticals Sales by Application (2017-2028)
        6.2.2 North America Radiopharmaceuticals Revenue by Application (2017-2028)
    6.3 North America Radiopharmaceuticals Market Size by Country
        6.3.1 North America Radiopharmaceuticals Sales by Country (2017-2028)
        6.3.2 North America Radiopharmaceuticals Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Radiopharmaceuticals Market Size by Type
        7.1.1 Europe Radiopharmaceuticals Sales by Type (2017-2028)
        7.1.2 Europe Radiopharmaceuticals Revenue by Type (2017-2028)
    7.2 Europe Radiopharmaceuticals Market Size by Application
        7.2.1 Europe Radiopharmaceuticals Sales by Application (2017-2028)
        7.2.2 Europe Radiopharmaceuticals Revenue by Application (2017-2028)
    7.3 Europe Radiopharmaceuticals Market Size by Country
        7.3.1 Europe Radiopharmaceuticals Sales by Country (2017-2028)
        7.3.2 Europe Radiopharmaceuticals Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Radiopharmaceuticals Market Size by Type
        8.1.1 Asia Pacific Radiopharmaceuticals Sales by Type (2017-2028)
        8.1.2 Asia Pacific Radiopharmaceuticals Revenue by Type (2017-2028)
    8.2 Asia Pacific Radiopharmaceuticals Market Size by Application
        8.2.1 Asia Pacific Radiopharmaceuticals Sales by Application (2017-2028)
        8.2.2 Asia Pacific Radiopharmaceuticals Revenue by Application (2017-2028)
    8.3 Asia Pacific Radiopharmaceuticals Market Size by Region
        8.3.1 Asia Pacific Radiopharmaceuticals Sales by Region (2017-2028)
        8.3.2 Asia Pacific Radiopharmaceuticals Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 China Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
9 Latin America
    9.1 Latin America Radiopharmaceuticals Market Size by Type
        9.1.1 Latin America Radiopharmaceuticals Sales by Type (2017-2028)
        9.1.2 Latin America Radiopharmaceuticals Revenue by Type (2017-2028)
    9.2 Latin America Radiopharmaceuticals Market Size by Application
        9.2.1 Latin America Radiopharmaceuticals Sales by Application (2017-2028)
        9.2.2 Latin America Radiopharmaceuticals Revenue by Application (2017-2028)
    9.3 Latin America Radiopharmaceuticals Market Size by Country
        9.3.1 Latin America Radiopharmaceuticals Sales by Country (2017-2028)
        9.3.2 Latin America Radiopharmaceuticals Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Radiopharmaceuticals Market Size by Type
        10.1.1 Middle East and Africa Radiopharmaceuticals Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Radiopharmaceuticals Revenue by Type (2017-2028)
    10.2 Middle East and Africa Radiopharmaceuticals Market Size by Application
        10.2.1 Middle East and Africa Radiopharmaceuticals Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Radiopharmaceuticals Revenue by Application (2017-2028)
    10.3 Middle East and Africa Radiopharmaceuticals Market Size by Country
        10.3.1 Middle East and Africa Radiopharmaceuticals Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Radiopharmaceuticals Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Bracco Imaging
        11.1.1 Bracco Imaging Corporation Information
        11.1.2 Bracco Imaging Overview
        11.1.3 Bracco Imaging Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Bracco Imaging Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Bracco Imaging Recent Developments
    11.2 Bayer
        11.2.1 Bayer Corporation Information
        11.2.2 Bayer Overview
        11.2.3 Bayer Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Bayer Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Bayer Recent Developments
    11.3 Mallinckrodt
        11.3.1 Mallinckrodt Corporation Information
        11.3.2 Mallinckrodt Overview
        11.3.3 Mallinckrodt Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Mallinckrodt Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Mallinckrodt Recent Developments
    11.4 Nordion
        11.4.1 Nordion Corporation Information
        11.4.2 Nordion Overview
        11.4.3 Nordion Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Nordion Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Nordion Recent Developments
    11.5 Triad Isotopes
        11.5.1 Triad Isotopes Corporation Information
        11.5.2 Triad Isotopes Overview
        11.5.3 Triad Isotopes Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Triad Isotopes Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Triad Isotopes Recent Developments
    11.6 Lantheus
        11.6.1 Lantheus Corporation Information
        11.6.2 Lantheus Overview
        11.6.3 Lantheus Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Lantheus Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Lantheus Recent Developments
    11.7 IBA Group
        11.7.1 IBA Group Corporation Information
        11.7.2 IBA Group Overview
        11.7.3 IBA Group Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 IBA Group Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 IBA Group Recent Developments
    11.8 GE Healthcare
        11.8.1 GE Healthcare Corporation Information
        11.8.2 GE Healthcare Overview
        11.8.3 GE Healthcare Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 GE Healthcare Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 GE Healthcare Recent Developments
    11.9 China Isotope & Radiation
        11.9.1 China Isotope & Radiation Corporation Information
        11.9.2 China Isotope & Radiation Overview
        11.9.3 China Isotope & Radiation Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 China Isotope & Radiation Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 China Isotope & Radiation Recent Developments
    11.10 Jubilant Pharma
        11.10.1 Jubilant Pharma Corporation Information
        11.10.2 Jubilant Pharma Overview
        11.10.3 Jubilant Pharma Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Jubilant Pharma Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Jubilant Pharma Recent Developments
    11.11 Eli Lilly
        11.11.1 Eli Lilly Corporation Information
        11.11.2 Eli Lilly Overview
        11.11.3 Eli Lilly Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Eli Lilly Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Eli Lilly Recent Developments
    11.12 Advanced Accelerator Applications
        11.12.1 Advanced Accelerator Applications Corporation Information
        11.12.2 Advanced Accelerator Applications Overview
        11.12.3 Advanced Accelerator Applications Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Advanced Accelerator Applications Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Advanced Accelerator Applications Recent Developments
    11.13 SIEMENS
        11.13.1 SIEMENS Corporation Information
        11.13.2 SIEMENS Overview
        11.13.3 SIEMENS Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
        11.13.4 SIEMENS Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
        11.13.5 SIEMENS Recent Developments
    11.14 Dongcheng
        11.14.1 Dongcheng Corporation Information
        11.14.2 Dongcheng Overview
        11.14.3 Dongcheng Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
        11.14.4 Dongcheng Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
        11.14.5 Dongcheng Recent Developments
    11.15 Navidea
        11.15.1 Navidea Corporation Information
        11.15.2 Navidea Overview
        11.15.3 Navidea Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
        11.15.4 Navidea Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
        11.15.5 Navidea Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Radiopharmaceuticals Industry Chain Analysis
    12.2 Radiopharmaceuticals Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Radiopharmaceuticals Production Mode & Process
    12.4 Radiopharmaceuticals Sales and Marketing
        12.4.1 Radiopharmaceuticals Sales Channels
        12.4.2 Radiopharmaceuticals Distributors
    12.5 Radiopharmaceuticals Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Radiopharmaceuticals Industry Trends
    13.2 Radiopharmaceuticals Market Drivers
    13.3 Radiopharmaceuticals Market Challenges
    13.4 Radiopharmaceuticals Market Restraints
14 Key Findings in The Global Radiopharmaceuticals Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Radiopharmaceuticals Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Diagnostic Radioisotopes
    Table 3. Major Manufacturers of Therapeutic Radioisotopes
    Table 4. Global Radiopharmaceuticals Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Radiopharmaceuticals Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Radiopharmaceuticals Sales by Region (2017-2022) & (K Dose)
    Table 7. Global Radiopharmaceuticals Sales Market Share by Region (2017-2022)
    Table 8. Global Radiopharmaceuticals Sales by Region (2023-2028) & (K Dose)
    Table 9. Global Radiopharmaceuticals Sales Market Share by Region (2023-2028)
    Table 10. Global Radiopharmaceuticals Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Radiopharmaceuticals Revenue Market Share by Region (2017-2022)
    Table 12. Global Radiopharmaceuticals Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Radiopharmaceuticals Revenue Market Share by Region (2023-2028)
    Table 14. Global Radiopharmaceuticals Sales by Manufacturers (2017-2022) & (K Dose)
    Table 15. Global Radiopharmaceuticals Sales Share by Manufacturers (2017-2022)
    Table 16. Global Radiopharmaceuticals Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Radiopharmaceuticals Revenue Share by Manufacturers (2017-2022)
    Table 18. Radiopharmaceuticals Price by Manufacturers (2017-2022) &(US$/Dose)
    Table 19. Global Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Radiopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceuticals as of 2021)
    Table 21. Radiopharmaceuticals Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Radiopharmaceuticals Product Offered
    Table 23. Date of Manufacturers Enter into Radiopharmaceuticals Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Radiopharmaceuticals Sales by Type (2017-2022) & (K Dose)
    Table 26. Global Radiopharmaceuticals Sales by Type (2023-2028) & (K Dose)
    Table 27. Global Radiopharmaceuticals Sales Share by Type (2017-2022)
    Table 28. Global Radiopharmaceuticals Sales Share by Type (2023-2028)
    Table 29. Global Radiopharmaceuticals Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Radiopharmaceuticals Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Radiopharmaceuticals Revenue Share by Type (2017-2022)
    Table 32. Global Radiopharmaceuticals Revenue Share by Type (2023-2028)
    Table 33. Radiopharmaceuticals Price by Type (2017-2022) & (US$/Dose)
    Table 34. Global Radiopharmaceuticals Price Forecast by Type (2023-2028) & (US$/Dose)
    Table 35. Global Radiopharmaceuticals Sales by Application (2017-2022) & (K Dose)
    Table 36. Global Radiopharmaceuticals Sales by Application (2023-2028) & (K Dose)
    Table 37. Global Radiopharmaceuticals Sales Share by Application (2017-2022)
    Table 38. Global Radiopharmaceuticals Sales Share by Application (2023-2028)
    Table 39. Global Radiopharmaceuticals Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Radiopharmaceuticals Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Radiopharmaceuticals Revenue Share by Application (2017-2022)
    Table 42. Global Radiopharmaceuticals Revenue Share by Application (2023-2028)
    Table 43. Radiopharmaceuticals Price by Application (2017-2022) & (US$/Dose)
    Table 44. Global Radiopharmaceuticals Price Forecast by Application (2023-2028) & (US$/Dose)
    Table 45. North America Radiopharmaceuticals Sales by Type (2017-2022) & (K Dose)
    Table 46. North America Radiopharmaceuticals Sales by Type (2023-2028) & (K Dose)
    Table 47. North America Radiopharmaceuticals Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Radiopharmaceuticals Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Radiopharmaceuticals Sales by Application (2017-2022) & (K Dose)
    Table 50. North America Radiopharmaceuticals Sales by Application (2023-2028) & (K Dose)
    Table 51. North America Radiopharmaceuticals Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Radiopharmaceuticals Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Radiopharmaceuticals Sales by Country (2017-2022) & (K Dose)
    Table 54. North America Radiopharmaceuticals Sales by Country (2023-2028) & (K Dose)
    Table 55. North America Radiopharmaceuticals Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Radiopharmaceuticals Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Radiopharmaceuticals Sales by Type (2017-2022) & (K Dose)
    Table 58. Europe Radiopharmaceuticals Sales by Type (2023-2028) & (K Dose)
    Table 59. Europe Radiopharmaceuticals Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Radiopharmaceuticals Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Radiopharmaceuticals Sales by Application (2017-2022) & (K Dose)
    Table 62. Europe Radiopharmaceuticals Sales by Application (2023-2028) & (K Dose)
    Table 63. Europe Radiopharmaceuticals Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Radiopharmaceuticals Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Radiopharmaceuticals Sales by Country (2017-2022) & (K Dose)
    Table 66. Europe Radiopharmaceuticals Sales by Country (2023-2028) & (K Dose)
    Table 67. Europe Radiopharmaceuticals Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Radiopharmaceuticals Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Radiopharmaceuticals Sales by Type (2017-2022) & (K Dose)
    Table 70. Asia Pacific Radiopharmaceuticals Sales by Type (2023-2028) & (K Dose)
    Table 71. Asia Pacific Radiopharmaceuticals Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Radiopharmaceuticals Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Radiopharmaceuticals Sales by Application (2017-2022) & (K Dose)
    Table 74. Asia Pacific Radiopharmaceuticals Sales by Application (2023-2028) & (K Dose)
    Table 75. Asia Pacific Radiopharmaceuticals Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Radiopharmaceuticals Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Radiopharmaceuticals Sales by Region (2017-2022) & (K Dose)
    Table 78. Asia Pacific Radiopharmaceuticals Sales by Region (2023-2028) & (K Dose)
    Table 79. Asia Pacific Radiopharmaceuticals Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Radiopharmaceuticals Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Radiopharmaceuticals Sales by Type (2017-2022) & (K Dose)
    Table 82. Latin America Radiopharmaceuticals Sales by Type (2023-2028) & (K Dose)
    Table 83. Latin America Radiopharmaceuticals Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Radiopharmaceuticals Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Radiopharmaceuticals Sales by Application (2017-2022) & (K Dose)
    Table 86. Latin America Radiopharmaceuticals Sales by Application (2023-2028) & (K Dose)
    Table 87. Latin America Radiopharmaceuticals Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Radiopharmaceuticals Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Radiopharmaceuticals Sales by Country (2017-2022) & (K Dose)
    Table 90. Latin America Radiopharmaceuticals Sales by Country (2023-2028) & (K Dose)
    Table 91. Latin America Radiopharmaceuticals Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Radiopharmaceuticals Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Radiopharmaceuticals Sales by Type (2017-2022) & (K Dose)
    Table 94. Middle East and Africa Radiopharmaceuticals Sales by Type (2023-2028) & (K Dose)
    Table 95. Middle East and Africa Radiopharmaceuticals Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Radiopharmaceuticals Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Radiopharmaceuticals Sales by Application (2017-2022) & (K Dose)
    Table 98. Middle East and Africa Radiopharmaceuticals Sales by Application (2023-2028) & (K Dose)
    Table 99. Middle East and Africa Radiopharmaceuticals Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Radiopharmaceuticals Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Radiopharmaceuticals Sales by Country (2017-2022) & (K Dose)
    Table 102. Middle East and Africa Radiopharmaceuticals Sales by Country (2023-2028) & (K Dose)
    Table 103. Middle East and Africa Radiopharmaceuticals Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Radiopharmaceuticals Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Bracco Imaging Corporation Information
    Table 106. Bracco Imaging Description and Major Businesses
    Table 107. Bracco Imaging Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 108. Bracco Imaging Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Bracco Imaging Recent Developments
    Table 110. Bayer Corporation Information
    Table 111. Bayer Description and Major Businesses
    Table 112. Bayer Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 113. Bayer Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Bayer Recent Developments
    Table 115. Mallinckrodt Corporation Information
    Table 116. Mallinckrodt Description and Major Businesses
    Table 117. Mallinckrodt Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 118. Mallinckrodt Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Mallinckrodt Recent Developments
    Table 120. Nordion Corporation Information
    Table 121. Nordion Description and Major Businesses
    Table 122. Nordion Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 123. Nordion Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Nordion Recent Developments
    Table 125. Triad Isotopes Corporation Information
    Table 126. Triad Isotopes Description and Major Businesses
    Table 127. Triad Isotopes Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 128. Triad Isotopes Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Triad Isotopes Recent Developments
    Table 130. Lantheus Corporation Information
    Table 131. Lantheus Description and Major Businesses
    Table 132. Lantheus Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 133. Lantheus Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Lantheus Recent Developments
    Table 135. IBA Group Corporation Information
    Table 136. IBA Group Description and Major Businesses
    Table 137. IBA Group Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 138. IBA Group Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. IBA Group Recent Developments
    Table 140. GE Healthcare Corporation Information
    Table 141. GE Healthcare Description and Major Businesses
    Table 142. GE Healthcare Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 143. GE Healthcare Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. GE Healthcare Recent Developments
    Table 145. China Isotope & Radiation Corporation Information
    Table 146. China Isotope & Radiation Description and Major Businesses
    Table 147. China Isotope & Radiation Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 148. China Isotope & Radiation Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. China Isotope & Radiation Recent Developments
    Table 150. Jubilant Pharma Corporation Information
    Table 151. Jubilant Pharma Description and Major Businesses
    Table 152. Jubilant Pharma Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 153. Jubilant Pharma Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Jubilant Pharma Recent Developments
    Table 155. Eli Lilly Corporation Information
    Table 156. Eli Lilly Description and Major Businesses
    Table 157. Eli Lilly Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 158. Eli Lilly Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. Eli Lilly Recent Developments
    Table 160. Advanced Accelerator Applications Corporation Information
    Table 161. Advanced Accelerator Applications Description and Major Businesses
    Table 162. Advanced Accelerator Applications Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 163. Advanced Accelerator Applications Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
    Table 164. Advanced Accelerator Applications Recent Developments
    Table 165. SIEMENS Corporation Information
    Table 166. SIEMENS Description and Major Businesses
    Table 167. SIEMENS Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 168. SIEMENS Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
    Table 169. SIEMENS Recent Developments
    Table 170. Dongcheng Corporation Information
    Table 171. Dongcheng Description and Major Businesses
    Table 172. Dongcheng Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 173. Dongcheng Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
    Table 174. Dongcheng Recent Developments
    Table 175. Navidea Corporation Information
    Table 176. Navidea Description and Major Businesses
    Table 177. Navidea Radiopharmaceuticals Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2017-2022)
    Table 178. Navidea Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
    Table 179. Navidea Recent Developments
    Table 180. Key Raw Materials Lists
    Table 181. Raw Materials Key Suppliers Lists
    Table 182. Radiopharmaceuticals Distributors List
    Table 183. Radiopharmaceuticals Customers List
    Table 184. Radiopharmaceuticals Market Trends
    Table 185. Radiopharmaceuticals Market Drivers
    Table 186. Radiopharmaceuticals Market Challenges
    Table 187. Radiopharmaceuticals Market Restraints
    Table 188. Research Programs/Design for This Report
    Table 189. Key Data Information from Secondary Sources
    Table 190. Key Data Information from Primary Sources
List of Figures
    Figure 1. Radiopharmaceuticals Product Picture
    Figure 3. Global Radiopharmaceuticals Market Share by Type in 2021 & 2028
    Figure 3. Diagnostic Radioisotopes Product Picture
    Figure 4. Therapeutic Radioisotopes Product Picture
    Figure 5. Global Radiopharmaceuticals Market Share by Application in 2021 & 2028
    Figure 6. Oncology
    Figure 7. Cardiology
    Figure 8. Other
    Figure 9. Radiopharmaceuticals Report Years Considered
    Figure 10. Global Radiopharmaceuticals Sales 2017-2028 (K Dose)
    Figure 11. Global Radiopharmaceuticals Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Radiopharmaceuticals Revenue 2017-2028 (US$ Million)
    Figure 13. Global Radiopharmaceuticals Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 14. Global Radiopharmaceuticals Sales Market Share by Region (2017-2022)
    Figure 15. Global Radiopharmaceuticals Sales Market Share by Region (2023-2028)
    Figure 16. North America Radiopharmaceuticals Sales YoY (2017-2028) & (K Dose)
    Figure 17. North America Radiopharmaceuticals Revenue YoY (2017-2028) & (US$ Million)
    Figure 18. Europe Radiopharmaceuticals Sales YoY (2017-2028) & (K Dose)
    Figure 19. Europe Radiopharmaceuticals Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Asia-Pacific Radiopharmaceuticals Sales YoY (2017-2028) & (K Dose)
    Figure 21. Asia-Pacific Radiopharmaceuticals Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Latin America Radiopharmaceuticals Sales YoY (2017-2028) & (K Dose)
    Figure 23. Latin America Radiopharmaceuticals Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Middle East & Africa Radiopharmaceuticals Sales YoY (2017-2028) & (K Dose)
    Figure 25. Middle East & Africa Radiopharmaceuticals Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. The Radiopharmaceuticals Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 27. The Top 5 and 10 Largest Manufacturers of Radiopharmaceuticals in the World: Market Share by Radiopharmaceuticals Revenue in 2021
    Figure 28. Global Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 29. Global Radiopharmaceuticals Sales Market Share by Type (2017-2028)
    Figure 30. Global Radiopharmaceuticals Revenue Market Share by Type (2017-2028)
    Figure 31. Global Radiopharmaceuticals Sales Market Share by Application (2017-2028)
    Figure 32. Global Radiopharmaceuticals Revenue Market Share by Application (2017-2028)
    Figure 33. North America Radiopharmaceuticals Sales Market Share by Type (2017-2028)
    Figure 34. North America Radiopharmaceuticals Revenue Market Share by Type (2017-2028)
    Figure 35. North America Radiopharmaceuticals Sales Market Share by Application (2017-2028)
    Figure 36. North America Radiopharmaceuticals Revenue Market Share by Application (2017-2028)
    Figure 37. North America Radiopharmaceuticals Sales Share by Country (2017-2028)
    Figure 38. North America Radiopharmaceuticals Revenue Share by Country (2017-2028)
    Figure 39. U.S. Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
    Figure 40. Canada Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
    Figure 41. Europe Radiopharmaceuticals Sales Market Share by Type (2017-2028)
    Figure 42. Europe Radiopharmaceuticals Revenue Market Share by Type (2017-2028)
    Figure 43. Europe Radiopharmaceuticals Sales Market Share by Application (2017-2028)
    Figure 44. Europe Radiopharmaceuticals Revenue Market Share by Application (2017-2028)
    Figure 45. Europe Radiopharmaceuticals Sales Share by Country (2017-2028)
    Figure 46. Europe Radiopharmaceuticals Revenue Share by Country (2017-2028)
    Figure 47. Germany Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
    Figure 48. France Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
    Figure 49. U.K. Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
    Figure 50. Italy Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
    Figure 51. Russia Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
    Figure 52. Asia Pacific Radiopharmaceuticals Sales Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Radiopharmaceuticals Revenue Market Share by Type (2017-2028)
    Figure 54. Asia Pacific Radiopharmaceuticals Sales Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Radiopharmaceuticals Revenue Market Share by Application (2017-2028)
    Figure 56. Asia Pacific Radiopharmaceuticals Sales Share by Region (2017-2028)
    Figure 57. Asia Pacific Radiopharmaceuticals Revenue Share by Region (2017-2028)
    Figure 58. China Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
    Figure 59. Japan Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
    Figure 60. South Korea Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
    Figure 61. India Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
    Figure 62. Australia Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
    Figure 63. China Taiwan Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
    Figure 64. Indonesia Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
    Figure 65. Thailand Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
    Figure 66. Malaysia Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
    Figure 67. Latin America Radiopharmaceuticals Sales Market Share by Type (2017-2028)
    Figure 68. Latin America Radiopharmaceuticals Revenue Market Share by Type (2017-2028)
    Figure 69. Latin America Radiopharmaceuticals Sales Market Share by Application (2017-2028)
    Figure 70. Latin America Radiopharmaceuticals Revenue Market Share by Application (2017-2028)
    Figure 71. Latin America Radiopharmaceuticals Sales Share by Country (2017-2028)
    Figure 72. Latin America Radiopharmaceuticals Revenue Share by Country (2017-2028)
    Figure 73. Mexico Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
    Figure 74. Brazil Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
    Figure 75. Argentina Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
    Figure 76. Middle East and Africa Radiopharmaceuticals Sales Market Share by Type (2017-2028)
    Figure 77. Middle East and Africa Radiopharmaceuticals Revenue Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Radiopharmaceuticals Sales Market Share by Application (2017-2028)
    Figure 79. Middle East and Africa Radiopharmaceuticals Revenue Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Radiopharmaceuticals Sales Share by Country (2017-2028)
    Figure 81. Middle East and Africa Radiopharmaceuticals Revenue Share by Country (2017-2028)
    Figure 82. Turkey Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
    Figure 83. Saudi Arabia Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
    Figure 84. UAE Radiopharmaceuticals Revenue (2017-2028) & (US$ Million)
    Figure 85. Radiopharmaceuticals Value Chain
    Figure 86. Radiopharmaceuticals Production Process
    Figure 87. Channels of Distribution
    Figure 88. Distributors Profiles
    Figure 89. Bottom-up and Top-down Approaches for This Report
    Figure 90. Data Triangulation
    Figure 91. Key Executives Interviewed